Inulin and fructo-oligosaccharides (FOS) are prebiotic fibres that feed beneficial gut bacteria
Phase 2: Clear (nasal therapy) Once you're stable on the full binder dose, the next step addresses suspected MARCoNS (Multiple Antibiotic Resistant Coagulase Negative Staphylococci), a colonization in the nasal passages that can keep inflammation going even after biotoxin removal
Loos, a professor at the University of Copenhagen and affiliated with a research center supported by the Novo Nordisk Foundation (the maker of Wegovy and Ozempic), noted, "The current model explains only 25% of the variability, and further research is needed to uncover the remaining 75%." However, she also expressed optimism, stating, "By combining genetic and clinical information, the era of personalized medicine, where we can select the best drug for each patient, may be upon us."
The peptide is a disulfide-cyclized octamer and is reported to have agonist activity on both hMC3R (EC 50 = 1.61 nM, E max = 84%) and hMC4R (EC 50 = 0.280 nM, E max = 95%) as shown in Table 1 (52)